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Regarding “Isolation of endothelial cells and their
progenitor cells from human peripheral blood”
We are writing in regard to your published article “Isolation
of endothelial cells and their progenitor cells from human periph-
eral blood” (J Vasc Surg 2000;31:181-9).
We read with interest Boyer et al’s article in Journal of
Vascular Surgery.1 We have been evaluating endothelial cell
extraction from many sources and seeding of vascular prosthesis
for many years; therefore, we investigated the possibility of cell
extraction from this source. The evidence so far suggests that
endothelial seeding of prosthetic graft improves graft patency
only when the source of the endothelial cells is vein and when the
cells are cultured.2,3 The recent report by Boyer et al has
described peripheral blood as another source of endothelial cells
for seeding vascular prosthesis. These cells were extracted using
CD34+ monoclonal antibody and then require prolonged culture
for 18 days before a typical cobblestone appearance was observed.
However, in their article, Boyer et al have not mentioned the total
number of CD34+ cells extracted from the 50 mL of blood and
the purity of their CD34+ cell extraction. To gather the feasibil-
ity of this source for seeding of prosthetic graft, we undertook
extraction of CD34+ cells from peripheral blood using a com-
mercial anti-CD34+ monoclonal antibody (HPCA-2, BD,
Oxford, United Kingdom).
A 29-year-old healthy volunteer had 50 mL of blood collected
into a tube containing 100 USP sodium heparin. The initial por-
tion of the blood was discarded to avoid contamination with
mature endothelial cells from the vein wall as per the technique of
Boyer et al. The blood was then mixed with an equal volume of
Hank’s balanced salt solution (HBSS) and mononuclear cells sep-
arated by discontinuous density gradient centrifugation (400 
“g”, 30 minutes). The mononuclear cell fraction was harvested
and labeled with CD34+ FITC antibody. CD34+ve progenitor
cells and endothelial cells were isolated by immunomagnetic sepa-
ration using a paramagnetic microbead conjugated to an anti-
FITC antibody (MACS VS, Miltentyi Biotec, Cologne, Germany).
The total number of mononuclear cells extracted using this
method was 61  106 (1.22  106/mL of blood). The total num-
ber of cells extracted using the immunomagnetic separation sys-
tem was 0.5  106 cells for 50 mL of blood. The purity of this
sample was 6.45%, so the total number of CD34+ cells was
32,250 cells, ie, 3.2  104 cells per 50 mL of blood (645
cells/mL).
In our experiment, we extracted 10 times more mononuclear
cells than Boyer et al did. However, our total number of pure
CD34+ cells was only 3.2  104 cells. Even if the purity were
15.7% as shown by Asahara et al,4 then the total number of cells
extracted would still be only 7.85  104 cells. This does not con-
stitute a large number of cells, which can be used for single stage
seeding, such as that required for polytetrafluoroethylene, where
2  105 cells per cm2 for graft are needed.5 We would also expect
the number of cells that can be extracted in an older patient to be
less and more likely to fail in culture.6 Regarding the two stage
seeding, we believe that an easier and proven source is vein allow-
ing up to 5.2  105 cells to be extracted from the external jugu-
lar vein.3,7 The endothelial cells from vein are easily cultured,
allowing a large number of cells to be available within 26 days.8
We would therefore conclude that the inadequate number of cells
that are extracted from peripheral blood and the prolonged cul-
ture required for them to differentiate into endothelial cells do
not allow their current use as a suitable source for seeding of
grafts for use in humans.
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Reply
We thank Dr Tiwari and colleagues for their interest in our
article and for the comparison of their data with ours. In the
experiments with adult peripheral blood, we were able to grow
large numbers of cells, enough for seeding of a graft as we
described on page 185, by placing the mononuclear cells, isolated
from a Ficoll gradient, into endothelial cell growth medium + calf
serum with iron. This was described as the best medium (Table I)
for umbilical cord blood; it was also best for adult peripheral
blood. The medium is permissive for endothelial cell development
and proliferation; other cells eventually lifted off the culture dish
or died, as did the initial cells exhibiting vasculogenesis. The
endothelial cells were not evident until most of the mononuclear
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